Tirzepatide side effects and insomnia: what the evidence says

Is insomnia actually caused by tirzepatide, or is something else going on?

This is the decision most people are quietly trying to make: whether broken sleep is the medicine's doing, or whether something else deserves the blame. The honest answer is that tirzepatide's prescribing information (the Mounjaro Summary of Product Characteristics on the eMC) does not list insomnia as a recognised common or uncommon side effect. That matters, because the clinical trials enrolled thousands of participants and captured adverse events systematically; if frank insomnia were a consistent pharmacological effect, it would appear in the data.

What the trials did record, consistently, is a cluster of gastrointestinal side effects: nausea, vomiting, reflux, constipation and indigestion. These peak in the days after starting treatment or after each dose step upward, and they do not stop when you lie down. Trying to sleep with active nausea or heartburn is difficult for obvious reasons, and this is the most plausible explanation for the sleep disruption many people describe. There is also a metabolic dimension: tirzepatide meaningfully reduces calorie intake, and the body's adjustment to a different energy state can affect cortisol rhythms and alertness patterns, at least temporarily. If you want to understand more about the side effects that tirzepatide can cause across treatment, including GI symptoms and the less commonly reported ones, that page gives a thorough overview. Explore the broader profile of tirzepatide side effects if you want a fuller picture of what to expect across treatment.

Separately, some people notice heightened energy or a slightly restless feeling in the first weeks, which may delay sleep onset even without nausea. This tends to settle. If you are wondering more specifically whether insomnia is a recognised side effect of Mounjaro, and what the evidence actually says, that question is addressed in detail on its own page. If your sleep disruption arrived well into treatment and is not linked to any GI symptoms, it is worth raising with your prescriber rather than attributing it to the medicine by default.

Factors that shape whether sleep is affected, and what you can do

The timing of your injection is a practical lever worth considering. Many people inject on a fixed day each week; if that day happens to be a Sunday evening, the worst of any GI adjustment can land mid-working week. Some find that shifting their injection to a morning slot, or to a day that suits their schedule (not unlike choosing when to take a medication around a bank holiday or a busy Monday) reduces the impact on sleep simply by giving nausea time to settle before bed. This is a conversation to have with your prescriber, not a change to make unilaterally.

Eating patterns matter too. Tirzepatide slows gastric emptying, so a large meal close to bedtime is more likely to cause overnight reflux and discomfort than it was before treatment. Smaller, earlier evening meals and staying upright for a couple of hours after eating are practical steps most people can try. Alcohol amplifies GI side effects and disrupts sleep architecture independently, so it is worth factoring in.

Mood and anxiety are also worth naming here. Starting a new medicine for weight management carries emotional weight for many people, and worry about side effects can itself interfere with sleep. The relationship between tirzepatide and mood changes is a distinct topic with its own evidence base; if you are noticing low mood or heightened anxiety alongside poor sleep, raise both with your prescriber at the same time. They are worth tracking together.

On the practical side, early side effects after your first dose are typically more pronounced than those that follow, which can be reassuring: what feels unsustainable in week one often looks quite different by week four.

When sleep problems need more than a timing adjustment

Most sleep disruption linked to tirzepatide is self-limiting. But there are situations where you should speak to a healthcare professional promptly, and a few where you need urgent help.

Contact your prescriber or GP without delay if sleep problems are accompanied by significant low mood, thoughts of self-harm, or a sense that your mental health is deteriorating. Changes in mood are listed in the Mounjaro prescribing information, and the NHS patient information for tirzepatide advises reporting mood changes to a doctor promptly.

Seek urgent medical attention if you experience severe abdominal pain, particularly pain that radiates toward your back, with or without vomiting, these are potential signs of pancreatitis, which the MHRA's January 2026 Drug Safety Update identified as a known but infrequent risk with GLP-1 receptor agonist medicines. Pain that wakes you from sleep and does not settle warrants a call to 111 or a visit to A&E if severe.

Other signs that need prompt assessment: symptoms of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), severe dehydration from persistent vomiting or diarrhoea, and sudden vision changes. If something feels wrong, act rather than wait.

For anything less acute (persistent broken sleep, discomfort that is affecting your quality of life, uncertainty about whether to continue) our prescribers discuss this as part of ongoing aftercare. You can also contact our support team seven days a week. And if you want to understand how Mounjaro works before or during treatment, the Mounjaro overview covers the mechanism, eligibility and what a full course of treatment involves.

Suspected side effects, including unusual sleep disturbance, can be reported to the MHRA at yellowcard.mhra.gov.uk. You do not need a diagnosis to file a report; your experience adds to the post-market evidence base that keeps prescribing information accurate.

If you are still deciding whether tirzepatide is right for you, or you have existing concerns about sleep, check your eligibility with our prescribers. That conversation covers your medical history, current medicines and any side effects you are already managing, not just BMI.